Rex Hoffman, M.D., MBA, says physician shortages and burnout are the most underestimated pressures on health system.
News|Articles|September 4, 2026
A conversation with Tiffany Phung, Pharm.D., CSP, about how patient outcomes drive specialty pharmacy strategy
Author(s)Logan Lutton
In this discussion, Tiffany Phung, Pharm.D., CSP, director of specialty pharmacy value, trade relations and market access at UC Davis Health, explores the challenges facing health system specialty pharmacies and how data-driven collaboration is shaping the future of patient care.
Advertisement
Advertisement
As specialty pharmacy becomes one of the fastest-growing areas of medicine, health systems are under pressure to show they can do more than dispense high-cost therapies — they need to prove they can manage the full patient journey. Limited distribution arrangements often shut health system pharmacies out of filling the very prescriptions their own teams identified, investigated and coordinated, even as rare disease treatments continue to expand.
Related to this article
Rex Hoffman, M.D., MBA, of Providence Holy Cross walks through a CMO’s day in a hospital that often runs 85% to 100% full, from safety huddles to discharges.
On average, caregivers want to see their children with ADHD fall asleep 30 minutes faster, but the best sleep treatments average approximately 20 minutes, a new survey study found.
Research findings presented at CHEST meeting show COPD hospital readmission drops with discharge checklists and navigation. Other research suggests targeting readmission prevention efforts on patents discharged to post-acute facilities.
As the pharmacist pipeline tightens, leaders from UC Davis Health, UCSF Health, and Sutter Health say financial sustainability now depends as much on capacity as on cost.
GLP-1 use in adults 65 and older with MASLD was linked to a 45% lower risk of death, and a 28% lower risk of hepatic decompensation, a new Houston Methodist Research Institute study shows.
New data from Sutter Health suggest the real gap in GLP-1 access is physician awareness, not insurance coverage — and fixing it closed outcome disparities across every racial and ethnic group.
Research findings presented at the CHEST meeting show that false positives may make patients more adherent to screening. Qualitative research shows that patients want more explanation and results communicated verbally.
Advertisement
Advertisement